COVID-19 Immune Evasion by the B.1.427/B.1.429 Variant of Concern

COVID-19 Immune Evasion by the B.1.427/B.1.429 Variant of Concern

As battles to contain the COVID-19 pandemic continue, attention is focused on emerging variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus that have been deemed variants of concern because they... read more

Full Vaccination Suppresses COVID-19 Delta Variant Mutation Frequency

Full Vaccination Suppresses COVID-19 Delta Variant Mutation Frequency

This study presents the first evidence that full vaccination against COVID-19 suppresses emergent mutations of SARS-CoV-2 delta variants. An evolution algorithm, Tajima's D test with a threshold value as -2.50, can provide... read more

Junior Doctors Write to Young People to Acknowledge Vaccine Concerns

Junior Doctors Write to Young People to Acknowledge Vaccine Concerns

A group of junior doctors from Scotland have written to young people in their age group to try to ease concerns they may have about receiving the covid-19 vaccine. In an open letter sent on Friday 6 August the doctors,... read more

Moderna Vaccine 94.1% Efficacy Preventing Symptomatic COVID-19

Moderna Vaccine 94.1% Efficacy Preventing Symptomatic COVID-19

The SARS-CoV-2 pandemic continues to be a global health concern. The mRNA-1273 (Moderna) vaccine was reported to have an efficacy of 94.1% at preventing symptomatic COVID-19 due to infection with ‘wild-type’ variants... read more

Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination

Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination

This study found an association between vaccination with BNT162b2 in hospital employees and a decreased risk of symptomatic and asymptomatic infections with SARS-CoV-2. Limitations include the observational design; short... read more

Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Johnson & Johnson Vaccination

Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Johnson & Johnson Vaccination

The initial 12 US cases of Cerebral Venous Sinus (CVST) with thrombocytopenia after Ad26.COV2.S (Janssen/Johnson & Johnson) vaccination represent serious events. This case series may inform clinical guidance as Ad26.COV2.S... read more

Simulated Identification of Silent COVID-19 Infections Among Children

Simulated Identification of Silent COVID-19 Infections Among Children

In this simulation modeling study of a synthetic US population, in the absence of vaccine availability for children, a targeted approach to rapidly identify silent COVID-19 infections in this age group was estimated to significantly... read more

Understanding The Links Between COVID-19 Vaccines and Thrombosis

Understanding The Links Between COVID-19 Vaccines and Thrombosis

The Advisory Committee on Immunization Practices (ACIP) is convening an emergency meeting to discuss adverse events that recently led to thrombotic events in 6 women administered the Johnson & Johnson COVID-19 vaccine in... read more

COVID-19 vaccines effective for pregnant women, likely protect their babies too

COVID-19 vaccines effective for pregnant women, likely protect their babies too

COVID-19 mRNA vaccines are extremely effective at protecting pregnant and lactating women against the virus, and likely provide protection for their babies as well, according to a study published March 25 in the American... read more

Vaccine-Induced Prothrombotic Immune Thrombocytopenia After AstraZeneca COVID-19 Vaccination

Vaccine-Induced Prothrombotic Immune Thrombocytopenia After AstraZeneca COVID-19 Vaccination

The United Kingdom, European Union, and Scandinavian countries have reported that the AstraZeneca COVID-19 vaccine appears to be associated with rare cases of serious blood clots, including blood clots in the brain. These... read more

The COVID-19 Vaccine: An Expert’s Medical Guide for All

The COVID-19 Vaccine: An Expert’s Medical Guide for All

Vaccine expert Zeil Rosenberg, M.D. shares his medical knowledge, backed by scientific data, about the development, safety and effectiveness of the new COVID-19 vaccines. Dr. Rosenberg M.D. is a Board-Certified Preventive... read more

Dr. Atul Gawande on why COVID-19 vaccinations will test American society

Dr. Atul Gawande on why COVID-19 vaccinations will test American society

The distribution of COVID-19 vaccines in America will test a deeply divided society, and not just because of mistrust in vaccinations, Atul Gawande, MD, told New Yorker Editor David Remnick. Dr. Gawande, longtime contributor... read more

CDC Tells States How to Prepare for Covid-19 Vaccine by Early November

CDC Tells States How to Prepare for Covid-19 Vaccine by Early November

The Centers for Disease Control and Prevention has notified public health officials in all 50 states and five large cities to prepare to distribute a coronavirus vaccine to health care workers and other high-risk groups as... read more

Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD

Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD

Influenza vaccination significantly reduced influenza-related hospitalization among patients with Chronic Obstructive Pulmonary Disease (COPD). Initiatives to increase vaccination uptake and early use of antiviral agents... read more

Last Year, The Flu Put Him In A Coma. This Year He’s Getting The Shot

Last Year, The Flu Put Him In A Coma. This Year He’s Getting The Shot

Charlie Hinderliter wasn't opposed to the flu shot. He didn't have a problem with vaccinations. He was one of about 53 percent of Americans who just don't get one. An estimated 80,000 Americans died of the flu, or flu-related... read more

Inside the lives of America’s last iron lung patients

Inside the lives of America’s last iron lung patients

Long after the polio vaccine stemmed the disease that once infected thousands of people, a handful of U.S. polio survivors still rely on decades-old iron lung machines to stay alive-and must overcome increasing obstacles... read more

Pharmacists Can Make a Difference During Influenza Pandemics

Pharmacists Can Make a Difference During Influenza Pandemics

Since November 2015, approximately 25% of adults who receive annual seasonal influenza vaccination are immunized in pharmacies or retail health care settings. The growth in vaccine uptake at pharmacies has public health policy... read more